First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like From pregnancy to pension: Mangoes improve diet, study shows January 23, 2024 Oil and gas activity may harm mental wellbeing before pregnancy July 12, 2024 New consensus provides evidence-based guidelines for second-degree burns June 2, 2024